Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No substantive changes detected between the two screenshots; the study details appear unchanged (title, objectives, eligibility criteria, and outcomes), with only minor formatting/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:09.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    4%
    Check dated 2025-10-05T10:19:55.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:38:19.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:21:51.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new pharmaceutical compounds like Sorafenib Tosylate and pembrolizumab. Notably, several previous entries related to locations and specific medical topics have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:58:58.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.